Haemonetics Corp. Files 2025 Annual Report
Ticker: HAE · Form: 10-K · Filed: May 21, 2025 · CIK: 313143
| Field | Detail |
|---|---|
| Company | Haemonetics Corp (HAE) |
| Form Type | 10-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, healthcare
TL;DR
Haemonetics filed its 2025 10-K. All systems go.
AI Summary
Haemonetics Corp. filed its 10-K for the fiscal year ending March 29, 2025. The company, based in Boston, MA, operates in the surgical and medical instruments sector. Key financial data and business operations for the period are detailed in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Haemonetics Corp.'s financial performance, strategic initiatives, and risk factors for the fiscal year 2025.
Risk Assessment
Risk Level: low — The filing is a standard annual report and does not indicate any immediate or unusual risks.
Key Numbers
- 0000313143 — Central Index Key (Unique identifier for Haemonetics Corp. in SEC filings.)
- 001-14041 — SEC File Number (SEC's file number for Haemonetics Corp.)
Key Players & Entities
- Haemonetics Corp. (company) — Filer of the 10-K report
- Boston, MA (location) — Company headquarters location
- March 29, 2025 (date) — Fiscal year end date
FAQ
What is Haemonetics Corp.'s primary business?
Haemonetics Corp. operates in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When did Haemonetics Corp.'s fiscal year end for this report?
The fiscal year end for this report was March 29, 2025.
Where is Haemonetics Corp. headquartered?
Haemonetics Corp. is headquartered in Boston, MA.
What is the accession number for this filing?
The accession number for this filing is 0000313143-25-000025.
What is the filing date of this 10-K report?
This 10-K report was filed on May 21, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on May 21, 2025 regarding HAEMONETICS CORP (HAE).